最新报道:According to Bijie.com, Faraday Future (NASDAQ: FFAI) announced today that it will make a strategic investment in Qualigen Therapeutics (NASDAQ: QLGN) through a $41 million PIPE transaction. Qualigen will be renamed CXC10 and transform into a crypto and Web3 business platform. CXC10 plans three growth engines: C10 Value Anchor, which includes the C10 Treasury (80% passive/20% active allocation), the first top 10 crypto asset index released by a publicly listed company, and the planned C10 ETF; BesTrade DeAl Agent, which will create a single gateway for users to enter the Web3 world; and Ecosystem Tokens, which include the Double Bridge RWA product connecting FFAI's industry data with digital finance, and the C10 stablecoin backed by the C10 Treasury and the US dollar. In addition to Faraday Future and Jia Yueting, CXC10 also includes the SIGN Foundation, a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, and China), IDG Capital, and Circle. Upon completion of the transaction, Faraday Future and Jia Yueting will collectively hold approximately 62% of CXC10. Jia Yueting will serve as Chief Advisor, and FF President Jerry Wang will serve as Co-CEO.
币界网消息,财联社10月29日电,谷歌表示,将TPUs(产品 ...
173